Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Profit After Tax

    Back to Income Statement
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Profit After Tax History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Profit After Tax ₹1,938 Cr₹2,007 Cr₹1,941 Cr₹1,310 Cr₹1,453 Cr

What is the latest Profit After Tax of MANKIND PHARMA ?

The latest Profit After Tax ratio of MANKIND PHARMA is ₹1,938 Cr based on Mar2026 Consolidated results.
Year Profit After Tax
Mar2026₹1,938 Cr
Mar2025₹2,007 Cr
Mar2024₹1,941 Cr
Mar2023₹1,310 Cr
Mar2022₹1,453 Cr

How is Profit After Tax of MANKIND PHARMA Trending?

Years Profit After Tax % Change
Mar2026 ₹1,938 Cr
-3.41
Mar2025 ₹2,007 Cr
3.39
Mar2024 ₹1,941 Cr
48.19
Mar2023 ₹1,310 Cr
-9.86
Mar2022 ₹1,453 Cr -

Compare Profit After Tax of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹94,040.1 Cr -1.9% -5.8% -12.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,958.0 Cr -3% -5.2% 17.9% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 0.2% 9.7% 56.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,233.0 Cr 1.3% 2% 36.5% Stock Analytics
CIPLA ₹110,273.0 Cr -2.2% -6.6% -10.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,906.4 Cr 1.4% -3.7% -8.8% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-1.9%

-5.8%

-12.9%

SENSEX

-2.3%

-4.1%

-7.4%


You may also like the below Video Courses